The global gastrointestinal stents market size reached USD 446.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 579.0 Million by 2033, exhibiting a growth rate (CAGR) of 2.9% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 446.3 Million |
Market Forecast in 2033
|
USD 579.0 Million |
Market Growth Rate 2025-2033 | 2.9% |
A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube that is placed in an anatomical duct, such as bile ducts, esophagus, bowel or colon, and blockages due to cancerous tissues. It aims to remove the obstruction and reduce the pressure caused by inflammation. Some of the most common types of gastrointestinal stents include biliary, colonic, duodenal, esophageal and pancreatic stents.
The rising prevalence of colorectal cancer across the globe is one of the key factors driving the growth of the market. Furthermore, an increasing geriatric population suffering from gastrointestinal diseases, such as bowel ailments, diverticulosis and gastrointestinal malignancies, is also providing a boost to the market growth. Additionally, the growing preference for minimally invasive (MI) surgical procedures, along with the rising health consciousness among the masses, is creating a significant impact on the market. In comparison to the traditional open surgery procedures, gastrointestinal stenting involves low risk of infections, minimal loss of blood and quick recuperation period. Moreover, various technological advancements, including the development of bio-absorbable and nitinol material-based stents offering a high degree of flexibility and kink-resistance, is acting as another growth-inducing factor. Other factors, including significant growth in the healthcare infrastructure, the implementation of favourable government policies and extensive research and development (R&D) activities, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal stents market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product type, technology type, material and end user.
Breakup by Product Type:
Breakup by Technology Type:
Breakup by Material:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Product Type, Technology Type, Material, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global gastrointestinal stents market was valued at USD 446.3 Million in 2024.
We expect the global gastrointestinal stents market to exhibit a CAGR of 2.9% during 2025-2033.
The rising demand for gastrointestinal stenting than open traditional surgery procedures, as it offers low risk of infections, long patency, minimal loss of blood, etc., is primarily driving the global gastrointestinal stents market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective gastrointestinal surgeries to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical devices, thereby negatively impacting the global market for gastrointestinal stents.
Based on the product type, the global gastrointestinal stents market has been divided into biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents. Among these, biliary stents currently account for the majority of the global market share.
Based on the technology type, the global gastrointestinal stents market can be categorized into anti-migratory stents, drug-eluting stents, radioactive stents, anti-reflux stents, shape-modified stents, and others. Currently, shape-modified stents exhibit a clear dominance in the market.
Based on the material, the global gastrointestinal stents market has been segregated into plastic stents, self-expanding metal stents, covered self-expandable metallic stents, and biodegradable or drug eluting stents. Among these, self-expanding metal stents hold the largest market share.
Based on the end user, the global gastrointestinal stents market can be bifurcated into hospitals, specialty clinics, ambulatory surgical centers, and others. Currently, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global gastrointestinal stents market include Becton, Dickinson and Company, Boston Scientific Corporation, Cantel Medical Corporation, Conmed Corporation, Cook Group Incorporated, ELLA-CS, S.R.O., Hobbs Medical Inc., Merit Medical Systems Inc., Olympus Corporation, Taewoong Medical Co. Ltd., etc.